通过增强诱饵ACE2来智取新型冠状病毒。 - Suppr

Outsmarting SARS-CoV-2 by empowering a decoy ACE2.

作者信息

Sokolowska Milena

机构信息

Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.

Christine Kühne - Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.

出版信息

Signal Transduct Target Ther. 2020 Nov 3;5(1):260. doi: 10.1038/s41392-020-00370-w.

DOI:10.1038/s41392-020-00370-w

PMID:33144557

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7607372/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bcc/7642267/c3142f6a7d26/41392_2020_370_Fig1_HTML.jpg

相似文献

Outsmarting SARS-CoV-2 by empowering a decoy ACE2.

Signal Transduct Target Ther. 2020 Nov 3;5(1):260. doi: 10.1038/s41392-020-00370-w.

A molecular trap against COVID-19.

Science. 2020 Sep 4;369(6508):1167-1168. doi: 10.1126/science.abe0010.

Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.

Rev Med Virol. 2020 Sep;30(5):e2122. doi: 10.1002/rmv.2122. Epub 2020 Jun 30.

Dynamics of the ACE2-SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms.

Sci Rep. 2020 Aug 26;10(1):14214. doi: 10.1038/s41598-020-71188-3.

Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.

Sci Rep. 2020 Oct 8;10(1):16862. doi: 10.1038/s41598-020-73820-8.

Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy.

Clin Sci (Lond). 2020 Jun 26;134(12):1301-1304. doi: 10.1042/CS20200623.

Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):591-597. doi: 10.11817/j.issn.1672-7347.2020.200299.

Gastrointestinal ACE2, COVID-19 and IBD: Opportunity in the Face of Tragedy?

Gastroenterology. 2020 Oct;159(4):1623-1624.e3. doi: 10.1053/j.gastro.2020.04.051. Epub 2020 Apr 27.

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.

Euro Surveill. 2020 Jul;25(28). doi: 10.2807/1560-7917.ES.2020.25.28.2000291.

SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure?

Eur Heart J. 2020 May 14;41(19):1807-1809. doi: 10.1093/eurheartj/ehaa410.

引用本文的文献

Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells.

Heliyon. 2023 Nov 20;9(12):e22614. doi: 10.1016/j.heliyon.2023.e22614. eCollection 2023 Dec.

Vaccines and Therapeutics for COVID-19 - How Can Understanding SARS-CoV-2 Glycosylation Lead to Pharmaceutical Advances?

Am Pharm Rev. 2021 May-Jun;24(4):14-21. Epub 2021 Jun 16.

Computational studies evidenced the potential of steroidal lactone to disrupt surface interaction of SARS-CoV-2 spike protein and hACE2.

Comput Biol Med. 2022 Jul;146:105598. doi: 10.1016/j.compbiomed.2022.105598. Epub 2022 May 13.

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants.

Sci Rep. 2021 Jun 17;11(1):12740. doi: 10.1038/s41598-021-91809-9.

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2.

Viruses. 2021 May 17;13(5):927. doi: 10.3390/v13050927.

本文引用的文献

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.

Science. 2020 Sep 4;369(6508):1261-1265. doi: 10.1126/science.abc0870. Epub 2020 Aug 4.

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.

Science. 2020 Aug 21;369(6506):1014-1018. doi: 10.1126/science.abd0831. Epub 2020 Jun 15.

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.

Allergy. 2020 Nov;75(11):2829-2845. doi: 10.1111/all.14429. Epub 2020 Aug 24.

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.

Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.

Nat Med. 2005 Aug;11(8):875-9. doi: 10.1038/nm1267. Epub 2005 Jul 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Outsmarting SARS-CoV-2 by empowering a decoy ACE2.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Outsmarting SARS-CoV-2 by empowering a decoy ACE2.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献